Study ProtocolEligible patients were randomly assigned to the sodium bicarbonate group or the sodium chloride group. Patients allocated to the 2 groups received 154 mmol/L of either sodium bicarbonate or sodium chloride. As soon as possible after admission, the following hydration protocol was started. The initial intravenous bolus was 3 ml·kg -1 ·h -1 for 1 h, if possible, before the coronary procedure. Patients subsequently received the same fluid at a rate of 1 ml·kg -1 ·h -1 J 2008; 72: 1610 -1614 (Received April 15, 2008 revised manuscript received May 26, 2008; accepted June 3, 2008; released online August 29, 2008 Background Contrast-induced nephropathy is associated with increased in-hospital and long-term adverse clinical outcomes.
Circ
Methods and ResultsTo investigate whether hydration with sodium bicarbonate improves long-term clinical outcomes compared with sodium chloride, patients with chronic kidney disease undergoing an emergent coronary procedure were enrolled in a randomized clinical trial with ≥1 year of follow-up. The 59 patients with chronic kidney disease (serum creatinine concentration >1.1 mg/dl or estimated glomerular filtration rate <60 ml/min) were randomly assigned to receive a 154 mmol/L intravenous infusion of either sodium bicarbonate (n=30) or sodium chloride (n=29). The electrolytes were given as a bolus of 3 ml·kg -1 ·h -1 for 1 h before the administration of contrast, followed by an infusion of 1 ml·kg -1 ·h -1 for 6 h during and after the procedure. During a mean follow-up period of 15.9±4.5 months, the incidence of renal replacement therapy or death was significantly lower in the sodium bicarbonate group than in the sodium chloride group (3% vs 21%, respectively; p=0.037).Conclusions Hydration with sodium bicarbonate reduces the incidence of renal replacement therapy and death in patients with chronic kidney disease undergoing an emergent coronary procedure. (Circ J 2008; 72: 1610 -1614